Author: FWA

Clinical Context Chronic low-grade inflammation is increasingly recognized as a central driver of metabolic disease progression. In obesity and prediabetes, dysfunctional adipose tissue becomes a source of pro-inflammatory cytokines (TNF-α, IL-6, MCP-1), while infiltrating macrophages perpetuate local and systemic inflammation. This inflammatory state contributes to insulin resistance, accelerates beta-cell dysfunction, and promotes atherosclerosis—creating a pathophysiological environment primed for type 2 diabetes and cardiovascular disease. Weight loss consistently reduces inflammatory markers, but whether different weight loss methods have differential effects on inflammation remains debated. Intermittent fasting (IF) and time-restricted eating (TRE) have gained substantial popularity, with proponents suggesting metabolic benefits beyond…

Read More

Clinical Context Cognitive decline and dementia represent enormous public health challenges, with limited effective treatments available. The MIND diet (Mediterranean-DASH Intervention for Neurodegenerative Delay) was specifically designed to protect brain health by combining elements of the Mediterranean and DASH diets with additional emphasis on foods associated with reduced dementia risk in observational studies—particularly green leafy vegetables, berries, nuts, and fish while limiting red meat, butter, cheese, pastries, and fried foods. Obesity is an established risk factor for cognitive decline, with mechanisms including inflammation, insulin resistance, cerebrovascular disease, and altered brain structure. The intersection of obesity and cognitive health suggests that…

Read More

Clinical Context Pediatric type 1 diabetes management is notoriously difficult, with most children and adolescents failing to achieve glycemic targets. Mean HbA1c levels in pediatric populations typically exceed 8%, well above the <7% target recommended for adults and the <7.5% target suggested for youth. The challenges are multifactorial: developmental changes in insulin sensitivity, unpredictable eating and activity patterns, psychological factors including diabetes distress and burnout, and the inherent complexity of replicating physiological insulin secretion with exogenous injections. Continuous glucose monitoring (CGM) has transformed diabetes care by providing real-time glucose data and trend information. However, CGM alone doesn’t improve outcomes—it’s what…

Read More

Clinical Context Diabetic foot ulcers (DFUs) remain a devastating complication in low- and middle-income countries, where limited access to specialized care and delayed presentation lead to high amputation rates. In India, an estimated 40,000 leg amputations occur annually due to diabetes, many preventable through basic foot care education. Prevention is far more effective than treatment: daily foot inspection, proper footwear, prompt attention to injuries, and regular professional foot examinations can dramatically reduce ulcer incidence. However, knowledge alone is insufficient. Many patients know what they should do but fail to maintain consistent foot care practices. The gap between knowledge and behavior…

Read More

Clinical Context Diabetic foot ulcers (DFUs) represent one of the most devastating and preventable complications of diabetes. In India, where diabetes prevalence has reached epidemic proportions, an estimated 40,000 leg amputations occur annually due to diabetes—many preventable through basic foot care education and early intervention. The economic burden of diabetic foot disease in low- and middle-income countries (LMICs) is catastrophic for families, often pushing households into poverty through lost income and healthcare costs. Prevention through education is far more effective than treatment of established ulcers. Daily foot inspection, proper footwear, hygiene practices, and prompt attention to minor injuries can dramatically…

Read More

Clinical Context Diabetic peripheral neuropathy affects up to 50% of patients with diabetes, and painful diabetic neuropathy (PDN) develops in 20-30% of those affected. The pain is characteristically described as burning, shooting, or stabbing, often worse at night and significantly impairing sleep and quality of life. Current pharmacological treatments—pregabalin, duloxetine, gabapentin, and tricyclic antidepressants—provide meaningful relief for only 30-50% of patients, and side effects (sedation, weight gain, cognitive impairment) limit tolerability. This unmet need drives interest in non-pharmacological approaches. Non-invasive peripheral nerve radiofrequency (NipRF) neuromodulation delivers energy transcutaneously, potentially providing benefits similar to implantable devices without invasive procedures. PICO Summary…

Read More

Clinical Context Hypoglycemia poses particular dangers in elderly patients with diabetes. The physiological warning symptoms that alert younger patients to low blood glucose—tremor, sweating, palpitations—become blunted with age and long-standing diabetes (hypoglycemia unawareness). Meanwhile, the consequences are magnified: falls and fractures, cardiac arrhythmias, cognitive impairment, and hospitalizations occur more frequently in older adults. Guidelines now recommend relaxed glycemic targets for elderly patients (HbA1c 7.5-8.5% depending on health status), recognizing that the harms of hypoglycemia often outweigh the benefits of intensive control in this population. Yet many elderly patients remain on high-risk regimens without adequate education on hypoglycemia prevention. The SUGAR…

Read More

Summary: In elderly individuals with type 2 diabetes at risk of hypoglycemia at outpatient diabetes clinics in Jordan, the SUGAR Handshake—a structured pharmacist-led educational intervention with hypoglycemia recognition education, prevention strategies, glucose diary maintenance, and behavioral support demonstrated high implementation fidelity (98.11% completion), excellent patient engagement (88-day diary completion average), and strong glucose monitoring adherence compared to usual diabetes care without structured hypoglycemia-focused education, with key barriers including age-related health limitations and psychological stress, while trust in pharmacists and social support served as facilitators. PICO Description Population Elderly individuals with type 2 diabetes at risk of hypoglycemia, enrolled in a…

Read More

Summary: In adults with STEMI undergoing primary PCI (stratified by BMI <25 vs ≥25 kg/m²), predominantly via radial access from the BRIGHT-4 trial, bivalirudin with prolonged high-dose infusion for 2-4 hours post-PCI demonstrated significant reduction in death or major bleeding in BMI <25 patients (3.2% vs 5.7%; HR 0.56) but no difference in BMI ≥25 patients (2.9% vs 2.9%) compared to heparin monotherapy during primary PCI without post-procedural infusion, with a statistically significant interaction between BMI and treatment effect (P-interaction = 0.04). PICO Description Population 6,016 adults with STEMI undergoing primary PCI, stratified by BMI (<25 kg/m² vs ≥25 kg/m²),…

Read More

Clinical Context Diabetic foot ulcers (DFUs) represent one of the most feared complications of diabetes, affecting up to 25% of patients during their lifetime and accounting for the majority of non-traumatic lower extremity amputations. Standard wound care—debridement, offloading, moisture management, and infection control—achieves complete healing in only 30-50% of cases. The persistent search for adjunctive therapies that can accelerate healing has led to exploration of numerous topical agents, including growth factors, bioengineered skin substitutes, and complementary therapies. Ozone (O₃) is a highly reactive form of oxygen with documented antimicrobial, anti-inflammatory, and tissue-healing properties. Ozone therapy has been used in medicine…

Read More